April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Xylocaine 2% - MPF injection, APP<br />
20 mg/mL, 2 mL vial (NDC 63323-0495-27)<br />
20 mg/mL, 5 mL vial (NDC 63323-0495-07)<br />
20 mg/mL, 10 mL ampule (NDC 63323-0496-97)<br />
Lidocaine 2% injection, Hospira<br />
20 mg/mL, 2 mL glass ampule, preservative-free (NDC 00409-4282-01)<br />
20 mg/mL, 5 mL vial, preservative-free (NDC 00409-2066-05)<br />
20 mg/mL, 20 mL vial (NDC 00409-4277-01)<br />
20 mg/mL, 50 mL vial (NDC 00409-4277-02)<br />
20 mg/mL, 10 mL glass ampule, preservative-free (NDC 00409-4282-02)<br />
20 mg/mL, 5 mL Ansyr plastic emergency syringes (NDC 00409-1323-05)<br />
Lidocaine 4%<br />
Xylocaine 4% injection, APP<br />
40 mg/mL, 5 mL glass ampule, preservative-free (NDC 63323-0490-89)<br />
Lidocaine 4% injection, Hospira<br />
40 mg/mL, 5 mL glass ampule, preservative-free (NDC 00409-4283-01)<br />
Reason for the Shortage<br />
• Hospira has lidocaine presentations on shortage due to manufacturing delays.<br />
• APP has Xylocaine and lidocaine presentations on shortage due to increased demand for the<br />
product.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=859<br />
Source: www.ashp.org<br />
Ciprofloxacin Injection<br />
March 28, <strong>2012</strong><br />
Products Affected - Description<br />
Ciprofloxacin injection, Claris<br />
2 mg/mL, 100 mL premixed bag (NDC 36000-0008-24)<br />
2 mg/mL, 200 mL premixed bag (NDC 36000-0009-24)<br />
Ciprofloxacin injection, Hospira<br />
10 mg/mL, 20 mL vial (NDC 00409-4765-86)<br />
10 mg/mL, 40 mL vial (NDC 00409-4778-86)<br />
Ciprofloxacin injection, Sagent<br />
2 mg/mL, 100 mL premixed bag (NDC 25021-0114-82)<br />
Ciprofloxacin injection, Teva<br />
2 mg/mL, 100 mL premixed bag (NDC 00703-0969-36) - discontinued<br />
2 mg/mL, 200 mL premixed bag (NDC 00703-0960-36) - discontinued<br />
10 mg/mL, 20 mL vial (NDC 00703-0956-03) - discontinued<br />
10 mg/mL, 40 mL vial (NDC 00703-0958-03) - discontinued<br />
Cipro injection, Merck<br />
2 mg/mL, 100 mL premixed bag (NDC 00085-1755-02) - discontinued<br />
2 mg/mL, 200 mL premixed bag (NDC 00085-1741-02) - discontinued<br />
10 mg/mL, 20 mL vial (NDC 00085-1763-03) - discontinued<br />
10 mg/mL, 40 mL vial (NDC 00085-1731-01) - discontinued<br />
Reason for the Shortage<br />
• Claris has recalled all lots of their ciprofloxacin premixed bags. More information can be found<br />
online.<br />
• Pfizer discontinued ciprofloxacin injection in 2010.<br />
70
Change language